Clinical Trials in North Carolina

Showing 14281-14300 of 20,428 trials

DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis

NCT02131324

The purpose of this study is to evaluate the potential of DFD06 cream to suppress the HPA (hypothalamic-pituitary-adrenal) axis as compared to clobetasol propionate cream, 0.05% cream when applied twice daily for 15 days.

Psoriasis

Promius Pharma, LLC50 participantsStarted May 2014

Glendale, Arizona, United States • Mesa, Arizona, United States • Encino, California, United States +12 more locations

COMPLETEDPhase 331 miles

Usability of an AI for M923 in Subjects With Moderate to Severe RA

NCT02722044

The purpose of this study is to evaluate the usability of an auto-injector (AI) for the delivery of M923 in patients with rheumatoid arthritis (RA)

Rheumatoid Arthritis

Momenta Pharmaceuticals, Inc.33 participantsStarted Apr 2016

Detroit, Michigan, United States • Greensboro, North Carolina, United States • Oklahoma City, Oklahoma, United States +4 more locations

DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis

Usability of an AI for M923 in Subjects With Moderate to Severe RA

Find Trials by Condition in North Carolina

Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy

Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia

Evaluation of a Commercial Program on Weight Loss and Health Outcomes

Phase 1 and 2 Study of PX-866 and Cetuximab

Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)

Gastrointestinal Tolerance Evaluation of an Infant Formula

A Study of the Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanced Cancers, Including Acute Myeloid Leukemia.

PF-00489791 For The Treatment Of Raynaud's

Vascular Inflammation in Psoriasis - Extension Study

Vascular Inflammation in Psoriasis Trial (The VIP Trial)

Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017

Safety of Oral Anticoagulants Registry

PK and Safety Study of Vaginal Rings Containing Dapivirine and Levonorgestrel

Study of PX-866 and Vemurafenib in Patients With Advanced Melanoma

Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers

Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches

Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)